Baldwin praises FDA for seeking change to blood donation policy
A plan by the Food and Drug Administration to move toward risk-based questions for blood donation rather than time-based deferrals has won praise from Sen. Tammy Baldwin, D-Wis.
To access this content, you must purchase a Premium membership, or log in if you are a member.
